Q&A with George Mulligan, PhD: ASP1128 Cuts Down on Acute Kidney Injuries
George Mulligan, PhD, discusses during Kidney Week the results of a phase IIa study showing potential in a new drug to treat patients at risk for developing an acute kidney injury following cardiovascular surgery.